Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial-Reference-Cited by-同舟云学术

Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial

Published:2016-01-13 Issue:3 Volume:18 Page:281-288
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Smits M. M.¹,Tonneijck L.¹,Muskiet M. H. A.¹,Kramer M. H. H.¹,Diamant M.¹,Pieters-van den Bos I. C.²,van Raalte D. H.¹,Cahen D. L.³

Affiliation:

1. Diabetes Centre, Department of Internal Medicine; VU University Medical Centre; Amsterdam The Netherlands

2. Department of Radiology and Nuclear Medicine; VU University Medical Centre; Amsterdam The Netherlands

3. Department of Gastroenterology and Hepatology; Erasmus University Medical Centre; Rotterdam The Netherlands

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12612/fullpdf

Reference48 articles.

1. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe?;Butler;Diabetes Care,2013

2. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies;Elashoff;Gastroenterology,2011

3. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study;Singh;JAMA Intern Med,2013

4. Incretin-based drugs and risk of acute pancreatitis: a nested-case control study within a healthcare database;Soranna;Diabetes Res Clin Pract,2015

5. Elevated amylase and lipase levels in patients using glucagonlike peptide-1 receptor agonists or dipeptidyl-peptidase-4 inhibitors in the outpatient setting;Lando;Endocr Pract,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetes;Diabetes, Obesity and Metabolism;2020-07

2. Pancreatic imaging: Current status of clinical practices and small animal studies;World Journal of Methodology;2017-09-26

3. Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial;Diabetes Care;2016-12-20

4. The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism;Journal of Translational Medicine;2016-07-30

5. Insulin Other Hypoglycemic Drugs;Side Effects of Drugs Annual;2016